Y Mabs Therapeutics Stock In The News
| YMAB Stock | USD 11.92 0.04 0.34% |
Our overall analysis of Y MAbs' news coverage and content from conventional and social sources shows investors' bearish mood towards Y mAbs Therapeutics. The specific impact of Y MAbs news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Y MAbs' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Y MAbs headlines in addition to utilizing other, more conventional financial analysis modules. Check out Y MAbs Backtesting and Y MAbs Hype Analysis.
YMAB |
Y MAbs Today Top News and Investor Outlook
Y mAbs Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide YMAB and other traded companies coverage with news coverage. We help investors stay connected with YMAB headlines for the 1st of December to make an informed investment decision based on correlating the impacts of news items on YMAB Stock performance. Please note that trading solely based on the Y mAbs Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Y MAbs stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the YMAB earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Y MAbs that are available to investors today. That information is available publicly through YMAB media outlets and privately through word of mouth or via YMAB internal channels. However, regardless of the origin, that massive amount of YMAB data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Y MAbs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Y MAbs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Y MAbs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Y MAbs alpha.
YMAB Largest EPS Surprises
Earnings surprises can significantly impact Y MAbs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-04 | 2021-09-30 | -0.6 | -0.66 | -0.06 | 10 | ||
2019-05-10 | 2019-03-31 | -0.41 | -0.47 | -0.06 | 14 | ||
2018-11-13 | 2018-09-30 | -0.36 | -0.42 | -0.06 | 16 | ||
2020-03-12 | 2019-12-31 | -0.67 | -0.6 | 0.07 | 10 | ||
2024-08-12 | 2024-06-30 | -0.13 | -0.21 | -0.08 | 61 | ||
2022-11-07 | 2022-09-30 | -0.71 | -0.63 | 0.08 | 11 |
Y MAbs Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Y mAbs Therapeutics Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
27th of November 2024
Y-mAbs to Participate at Citis 2024 Global Healthcare Conference at gurufocus.com
21st of November 2024
Y-mAbs Therapeutics, Inc. Given Consensus Rating of Moderate Buy by Brokerages - MarketBea... at news.google.com
15th of November 2024
Y-mAbs Therapeutics Trading Down 8.5 percent Heres What Happened at thelincolnianonline.com
11th of November 2024
BMO cuts YMAB stock target on Q3 revenue miss at investing.com
8th of November 2024
Y-mAbs Therapeutics Inc Reports Q3 2024 Revenue of 18.5 Million, EPS of 0. ... at gurufocus.com
5th of November 2024
Vanguard Group Incs Strategic Acquisition in Y-mAbs Therapeutics Inc at gurufocus.com
31st of October 2024
Bristol Myers Squibb Tops Q3 Earnings and Revenue Estimates at zacks.com
9th of October 2024
Y-mAbs Therapeutics Inc Q2 2024 Earnings Call Highlights Revenue Growth Driven by ... at gurufocus.com
6th of September 2024
Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at A... at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Y MAbs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Y MAbs' short interest history, or implied volatility extrapolated from Y MAbs options trading.
Check out Y MAbs Backtesting and Y MAbs Hype Analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Y MAbs. If investors know YMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Y MAbs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 1.921 | Quarterly Revenue Growth (0.1) | Return On Assets (0.12) | Return On Equity (0.25) |
The market value of Y mAbs Therapeutics is measured differently than its book value, which is the value of YMAB that is recorded on the company's balance sheet. Investors also form their own opinion of Y MAbs' value that differs from its market value or its book value, called intrinsic value, which is Y MAbs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Y MAbs' market value can be influenced by many factors that don't directly affect Y MAbs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Y MAbs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Y MAbs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Y MAbs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.